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ABSTRACT 
Upon DNA damage, the cell fate decision between survival and apoptosis is largely 
regulated by p53-related networks. Recent experiments found a series of discrete p53 
pulses in individual cells, which led to the hypothesis that the cell fate decision upon 
DNA damage is controlled by counting the number of p53 pulses. Under this hypothesis, 
Sun et al. (2009) modeled the Bax activation switch in the apoptosis signal transduction 
pathway that can rigorously “count” the number of uniform p53 pulses. Based on 
experimental evidence, here we use variable p53 pulses with Sun et al.'s model to 
investigate how the variability in p53 pulses affects the rigor of the cell fate decision by 
the pulse number. Our calculations showed that the experimentally anticipated 
variability in the pulse sizes reduces the rigor of the cell fate decision. In addition, we 
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tested the roles of the cooperativity in PUMA expression by p53, finding that lower 
cooperativity is plausible for more rigorous cell fate decision. This is because the 
variability in the p53 pulse height is more amplified in PUMA expressions with more 
cooperative cases.  
 




 DNA damage in cells leads to either the induction of apoptosis or activation of DNA 
repair and cell cycle arrest, depending on the level of DNA damage1-3, which is termed 
the "cell fate decision". The precise decision is of central importance and disorder of 
apoptosis signal transduction often causes serious diseases such as cancer and 
neurodegenerative disease4-6. In the cell fate decision process, p53, a well-known 
tumor-suppressor transcription factor, plays key roles by regulating the transcription of 
many kinds of genes responsible for cell cycle control, DNA repair, and apoptosis 
induction2, 7.  
 Recently, it was reported that, upon DNA damage by gamma ray radiation, a series of 
discrete pulse-like p53 concentration changes (called p53 pulses in this article) were 
observed in tumor cell lines in individual cells8-12. It was suggested that the level of DNA 
damage does not severely affect the mean size or shape of each pulse, but correlates 
with the number of p53 pulses10. The p53 pulses may be generated when the level of 
DNA damage exceeds a particular threshold. A plausible hypothesis is that a cell 
“counts” the successive p53 pulses and decides the cell fate by the number of pulses13. 
In other words, the difference in the p53 pulse number elicits a different cellular 
response, apoptosis or survival; however, the details of the p53 pulse counting 
mechanism of cells and the relationship between the p53 pulse number and the cell fate 
decision remain largely unclear. 
 Currently, several studies using computational systems biology have elucidated the 
p53 pulse-counting mechanism and the relationship between the p53 pulse and the cell 
fate decision14-21. For example, Sun et al. (2009) modeled a Bax activation switch that 
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counts the number of p53 pulses and decides the cell fate. In their work, the dynamics 
was deterministic and the p53 pulse size and shape were fixed. Thus, when the pulse 
number was larger than the threshold, cells always underwent apoptosis, whereas 
when the pulse number was below the threshold, cells always survived. The cell fate 
decision is completely rigorous depending on the pulse number. The threshold of the 
p53 pulse number that divides apoptosis from survival depends on their model details 
and kinetic parameters. Experiments suggested, however, that the pulse size and shape 
are variable9-10. More precisely, the pulse heights (also called amplitude), pulse widths, 
and pulse intervals (also called period) are not constants, but are variable. For example, 
the pulse heights of different pulses in the same cell can vary by about 3-fold10. This 
variability apparently complicates the rigorous cell fate decision. Zhang et al. (2009b) 
included variability in terms of the initial level of DNA damage and its repair dynamics, 
while the pulse size was still deterministic and fixed. The main purpose of this paper 
was to address the effects of variability in p53 pulses. How the variability affects the 
rigor of cell fate decision by counting the pulse number is investigated.  
 Signal transductions from p53 to the induction of apoptosis have been intensively 
studied and many components identified experimentally. The p53-based apoptosis 
signals are transmitted to mitochondria, especially to Bcl-2 family proteins that mutually 
interact at the mitochondrial outer membrane. Bcl-2 family proteins induce cytochrome c 
release from mitochondria to cytoplasm, and released cytochrome c enhances the 
activation of caspase in cytoplasm. Then, caspase activation turns on cascade 
reactions, leading to various apoptotic morphological changes5, 22. Most of the members 
of Bcl-2 family proteins are known to be located at the mitochondrial outer membrane 
and interact with each other. Bcl-2 family proteins can be classified into 3 groups, (1) 
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pro-apoptotic Bcl-2 family proteins (Bax etc), (2) anti-apoptotic Bcl-2 family proteins 
(Bcl-2, Mcl-1 etc), (3) BH3-only proteins (PUMA, NOXA, Bid etc). BH3-only proteins can 
be further divided into 2 subgroups, called activator BH3-only proteins (Bid etc) and 
sensitizer (also called enabler) BH3-only proteins (PUMA, NOXA etc). Pro-apoptotic 
Bcl-2 family proteins and BH3-only proteins facilitate apoptosis, whereas anti-apoptotic 
Bcl-2 family proteins counteract them and facilitate survival. Interactions and balances 
among Bcl-2 family proteins are thought to be crucial for the precise cell death 
decision23-24. For p53 to enhance apoptosis, p53 activates the expression of several 
kinds of Bcl-2 family proteins22, 25. In particular, PUMA, one of the sensitizer BH3-only 
proteins, is a main transcriptional target of p53 in various tissues26-28. In computational 
systems biology studies, Sun et al. (2009) suggested that the Bax activation switch can 
count p53 pulses through PUMA accumulation and decide the cell fate. Our modeling is 
largely based on the signal transduction model of Sun et al. (2009). We note that Sun et 
al.'s model has not been verified experimentally. To experimentally verify their 
suggestion, we need to observe and examine the relationship between the number of 
p53 pulses which are directly related to the expression of PUMA and subsequent 
apoptosis. 
 In the gene expression by p53, p53 binds to the target DNA in the tetramer form in a 
highly cooperative manner29-30. This highly cooperative binding of p53 to DNA is a 
source of its nonlinear nature. In the latter part of this paper, we investigate how 
cooperativity in PUMA expression by p53 affects the rigor of cell fate decision. 
 
In this study, based on the modeling of Sun et al. (2009), we investigated how the 
variable p53 pulse size affects the rigor of cell fate decision. We explored the factors 
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which influence the rigor of cell death decision by the apoptosis signal transduction 
pathway. In particular, we focused on the cooperativity of PUMA expression by p53 
because a highly cooperative process is thought to be the source of its nonlinear nature 




Model of the apoptosis signal transduction pathway 
In this study, we adopted a subset of the model of the apoptosis signal transduction 
pathway developed by Sun et al. (2009). In particular, to focus on the probabilistic 
nature of the apoptosis signal transduction pathway, we selected only the core of the 
bifurcation module, “Bax activation switch module”, from the model of Sun et al. (2009) 
(Figure 1).  
We briefly describe the model in Figure 1. The input stimulus for apoptosis induction in 
this model is p53 pulses, which is supposed to be produced by gamma ray 
radiation-based DNA damage. Increased p53 concentration enhances the transcription 
of PUMA, one of the sensitizer BH3-only proteins. The output signal for apoptosis in this 
model is pore formation on the mitochondrial outer membrane. The pore transports 
cytochrome c from the mitochondria to cytoplasm, and the cytoplasmic cytochrome c 
activates caspases, which then induce apoptosis. Since downstream from the pore 
formation is relatively straightforward, we do not include it here. The pore is an oligomer 
(here assumed as a dimer following Sun et al. (2009)) of activated Bax, pro-apoptotic 
Bcl-2 family proteins. A monomeric Bax takes two forms, inactive Bax (denoted as Bax) 
and activated Bax (denoted as AcBax). Binding of two AcBaxs as well as binding of 
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AcBax with Bax leads to pore formation. Activator BH3-only proteins (denoted as Act) 
activate Bax to form activated Bax (AcBax). Bcl-2, one of the anti-apoptotic Bcl-2 family 
proteins, is a key player, which binds to and sequesters activated Bax, and also inhibits 
Act to activate Bax. PUMA binds to Bcl-2, which reduces Bcl-2 binding to its targets, Act 
and AcBax. We note that PUMA expressed by p53 stimulus activates Bax not directly, 
but indirectly, leading to apoptosis enhancement23-24. In the model, all the protein 
interactions (all dashed lines in Figure 1) except the arrow from p53 to PUMA are 
protein interactions, and the arrow from p53 to PUMA represents transcription regulation. 
Based on static bifurcation analysis (see Steady state bifurcation analysis in Results), 
we can unambiguously define the onset of apoptosis when the pore concentration is 
over 100.0 (nM) after a sufficient time (3000min in this work).  
 
Model representation by ordinary differential equations, kinetic parameters and 
initial conditions 
All protein interactions in this model are represented by ordinary differential equations 
following mass-action kinetics (Table 1). Only the expression process of PUMA by p53 
is represented by the Hill function, as in Sun et al. (2009). 
By default, we used the same kinetic parameters as in Sun et al. (2009), but changed 
several kinetic parameters of the expression process of PUMA by p53 based on 
experimental data28, 30 (Table 2).  As for the maximum rate of PUMA synthesis by p53 
(“kssp53” in Table 2), it was set 10 times higher than the PUMA basal production rate 
based on Yu et al. (2001). We set the Hill coefficient of PUMA expression by p53 as 2.0, 
by default, (“n” in Table 2) because an in vitro experiment showed that p53 binding to 
DNA has a Hill coefficient of 1.830. 
8 
In this study, for simplification, we assumed that p53 concentration is zero without DNA 
damage. The initial conditions of all proteins were set at the steady state concentrations 
when the p53 concentration was zero. 
 
p53 pulse representation 
Experiments suggested that p53 pulse heights, widths and intervals do not significantly 
depend on the level of DNA damage, and have their own mean values as well as their 
own variability9-10. The measured mean values and standard deviations (SD) of p53 
pulse widths and intervals are 350.0 ± 160.0 (min) and 440.0 ± 100.0 (min), respectively 
(mean value ± SD)10. As for the p53 pulse heights, although the coefficient of variation 
(CV = SD/mean value) was experimentally estimated as 0.79, the mean height itself was 
not reliably measured. Therefore, we chose the mean height for each simulation by a 
certain criterion (see Minimum pulse height for apoptosis in Results for the details); 
without the variability in the pulse, apoptosis occurs after a certain number of pulses.  
 Instead of generating p53 pulses by the p53-Mdm2 interaction network module, here 
we gave the p53 pulses as Gaussian functions. Namely, the concentration of the n-th 
p53 pulse is represented by. 
 
     (1) 
 
Here “[p53]” is the p53 concentration (nM) at time “t” (min), “H” represents the pulse 
height (nM), “μ” is the peak time of the first pulse set as "pulse width/2"(min), and “σ” 
represents the width of the pulse set as “p53 pulse width / 6” (min). Factor 6 comes from 
the difference in the definition of the "width". The experimentally measured "p53 pulse 
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width" is the time difference between the onset and the end of the pulse, while σ is the 
"width" in Gaussian function. D represents the pulse interval (min).  
 To represent variable p53 pulse heights, widths, and intervals, we used random 
numbers. For σ, and D, random numbers were generated from the normal distribution 
with the above mentioned means and SDs. Pulse height was generated for the normal 
distribution with a given mean and SD = 0.7 x mean. Figure 2 illustrates the generated 
p53 pulses. 
 
Calculation of apoptosis probability 
We performed 1000 independent calculations with variable p53 pulses. The apoptosis 
probability is estimated as the ratio of the cases in which apoptosis occurred by the end 
of calculations (3000min). 
 
Numerical calculation 
Steady state concentrations of all proteins were calculated by solving the simultaneous 
equations obtained by setting all ordinary differential equations equal to zero with the 
standard Newton-Raphson method. Local stabilities of all steady states were 
determined by evaluating eigenvalues of Jacobian matrices, which were obtained by 
linearization of ordinary differential equations. 
In the dynamics calculations, the ordinary differential equations were numerically 





Steady state bifurcation analysis 
 We started with the standard steady state bifurcation analysis of the model (Figure 3). 
In the figure, red and blue curves indicate stable and unstable steady states, 
respectively. As described above, steady states with a high pore concentration 
correspond to the apoptosis state, while those with low (basal) pore concentration 
represent the survival (non-apoptosis) state. Indeed, Figure 3A shows two discrete 
stable states, one apoptotic and the other survival. In this bistable system, increasing 
the p53 concentration, the survival state suddenly disappears and abrupt transition from 
the survival state to the apoptosis state occurs at a threshold p53 concentration (solid 
arrow in Figure 3A). Once a high level of pore is accumulated (i.e., apoptosis state), it is 
sustained even when the p53 concentration returns to the level below the threshold 
(x-marked dashed arrow in Figure 3A). Thus, the system shows irreversibility. It has 
been suggested experimentally as well as computationally that the interaction network 
of Bcl-2 family proteins at mitochondria exhibits bistable Bax activation and pore 
formation16, 31-33. In particular, two positive feedbacks, Bax auto-activation and Bcl-2 
binding to activated Bax, were thought to be the origin of the bistable nature32. 
Apparently, bistability and irreversibility are important for the apoptosis signal 
transduction pathway to avoid improper apoptosis induced by noise, or the appearance 
of malignant cells by improper survival34-35.  
 In this study, we address the cooperativity of PUMA expression regulation by p53, 
which is represented by the Hill coefficient, “n” in Stimulus term in Eq. (7) in Table 1. The 
default is n = 2.0 (Figure 3A), but we will also examine cases with n = 1.0 and 4.0. Thus, 
we show bifurcation diagrams for n = 1.0 and n = 4.0 (Figure 3B and C). As the Hill 
coefficient increases, the threshold p53 concentration increases, whereas the pore 
11 
concentrations in the apoptosis and survival states do not alter very much. In all cases, 
Figures 3 robustly shows the bistability and irreversibility of pore formation by p53 
concentration changes. These are essentially the same as the results in Sun et al. 
(2009), which dealt with more comprehensive signal transduction networks. Based on 
these bifurcation analyses, we set the criterion for the pore concentration in the 
apoptosis state as >100.0 (nM).  
 
Minimum pulse height for apoptosis 
 We then performed dynamic analysis of the model. Before analyzing the roles of 
variability in the p53 pulses, a uniform p53 pulse was examined as a control. The 
minimum pulse height necessary for apoptosis induction was calculated for each given 
pulse number (Table 3). Here, the pulse width and interval were set as 350.0 (min) and 
440.0 (min), respectively, based on the above argument (see p53 pulse representation 
in Methods). As the pulse number increases, the required minimal pulse height for 
apoptosis induction becomes smaller. In addition, a larger pulse height is necessary for 
apoptosis induction as the Hill coefficient becomes larger. The calculated data of the 
minimum pulse height was used in the following sections to calculate the probability of 
apoptosis onset. 
 
The rigor of cell fate decision and p53 pulse size variability  
 Now, variability was introduced into the p53 pulse size to assess how it affected the 
rigor of cell fate decision. Experimentally, the number of p53 pulses to induce apoptosis 
is unclear. In the computational study of Sun et al. (2009), with their parameter choices, 
the cell underwent apoptosis when the pulse was ≥3. Here, here we simply followed 
12 
their model by setting the pulse height as 237.5 (nM), which is between the minimum 
pulse height for 2-pulse apoptosis induction and that for 3-pulse apoptosis induction 
(Table 3). For the pulse size variety, SDs and the coefficient of variation described in 
p53 pulse representation in Methods were used as a reference. These values are based 
on experiments of tumor cell lines9-10. It was argued that normal cells may have less 
variability than tumor cells36; therefore, based on the degree of variability in tumor cells 
(designed as "pulse_variability = 1"), we also tested reduced variability cases by a factor 
of 0.5 ("pulse_variability = 0.5”), 0.25 (“pulse_variability = 0.25”), and 0 
("pulse_variability = 0" corresponding to deterministic cases). For example, when 
“pulse_variability = 0.5”, the SD of pulse width was set to 80.0, the SD of pulse interval 
was set to 50.0, and the coefficient of variation of pulse height was set to 0.35. 
 Figure 4 shows apoptosis probability as a function of the number of variable p53 
pulses. Without variability (“pulse_variability = 0”), with our choice of pulse height, the 
apoptosis probability suddenly changed from 0 % for 2 pulses to 100 % for 3 pulses. 
Due to the deterministic nature, the cell fate decision is completely rigorous. With 
“pulse_variability = 0.25”, the cell fate decision curve softened, still showing sigmoidal 
behavior. As the pulse_variability increased, the sigmoidal nature was reduced, and the 
curves became hyperbolic. These results indicate that p53 pulse variability lowers the 
rigor of the cell fate decision. In normal cells, pulse height, width and interval are thought 
to fluctuate to some extent, as assumed in this study. With variable p53 pulse sizes, 
completely rigorous cell fate decision is difficult. 
Recently, Zhang et al. (2009b) also investigated the variability in the cell fate decision. 
They investigated the stochasticity of the initial DNA damage and its repair dynamics as 
the source of cell fate variability, whereas the pulse size was deterministic. It is probable 
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that variable initial DNA damage and its repair dynamics, together with intrinsic 
stochasticity, may induce variable p53 pulse sizes. Thus two means of variability are 
related, but not identical. In addition, all biochemical reactions should have intrinsic 
stochasticity, which further lowers the rigor of the cell fate decision. Considering these 
multiple sources of stochasticity will be a future study. 
 
Role of cooperativity in the rigor of cell fate decision by variable p53 pulses 
 Finally, we investigated how the rigor of the cell fate decision by variable p53 pulse 
sizes is affected by the cooperativity in PUMA expression regulation by p53. Until this 
point we had used the default Hill coefficient of n = 2.0, but here we also used n = 1.0 
and 4.0. The mean pulse heights were set to 77.5 (nM) for n = 1.0 and 380.0 (nM) for n 
= 4.0, respectively, which were chosen in the same way as the default n = 2.0. Figure 5 
shows apoptosis probability as a function of the pulse number. Quite surprisingly, it was 
seen that, for the same degree of pulse variability, a larger Hill coefficient exhibits less of 
a sigmoidal curve. Namely, with larger cooperativity in PUMA expression regulation by 
p53, the cell fate decision becomes less rigorous.  
Experimentally, the exact Hill coefficient for PUMA expression regulation by p53 in 
living cells is unclear. Weinberg et al. (2004) estimated it to be 1.8 by in vitro 
experiments using p53CT (residues 94-360) and synthesized DNA. Some of the earlier 
computational studies used n = 3.0 or 4.016, 20, probably based on the fact that p53 is a 
tetramer and its binding to DNA is highly cooperative29.  
 
 Why did a larger Hill coefficient lead to a less pronounced sigmoid curve? First, it was 
investigated, among the three types of variability in the pulses, which variability had the 
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largest impact on the rigor of cell fate decision. We repeated the apoptosis probability 
calculations, but by setting one of three SDs as zero (Figure 6). In Figure 6, we can see 
that there was almost no difference among the three Hill coefficients when the pulse 
height was constant. In contrast, when the pulse width or pulse interval was constant, 
the rigor of cell fate decision seemed to depend on the Hill coefficient, similar to the 
Figure 5 result. These results suggest that the pulse height variability seems to be 
almost the sole factor influencing the rigor of cell fate decision.  
 
Next, we tried to elucidate why pulse height variability strongly influences the rigor of 
cell fate decision. For example, in the case of pulse_variability = 0.5, the p53 pulse 
height was distributed across 154–320nM when the Hill coefficient equaled 2.0. These 
ranges were input into the Stimulus term      (2) 
 
to obtain the distribution range in PUMA concentration. We show these ranges in Table 
4 for different Hill coefficients (“ST range” and its width “RWS”). For better comparison, 
Table 4 also contains the relative ranges, the ranges divided by the mean (“NRWS”). 
The results in Table 4 clearly shows that, as the Hill coefficient increases, the variability 
in the p53 pulse height more strongly amplifies the variability in the PUMA concentration 
(variability in Stimulus), which results in the uncertainty of cell fate decision. In the 
current model, PUMA accumulates over p53 pulses. When the PUMA concentration 
exceeds a threshold, Bax activation is switched on; therefore, the cumulative amount of 
p53 within a certain time scale is a key factor. We calculated the cumulative amount of 
p53 pulses above the pore formation thresholds in Figure 3 while varying each of the 
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three pulse characteristics (height, width and interval). Calculated averages of integrals 
and coefficient of variations (CV) of integrals were, respectively, 88884.88 (nM*min) and 
0.25634 when the height was varied, 84848.08 (nM*min) and 0.10233 when the width 
was varied, and 84734.55 (nM*min) and 0.00010 when the interval was varied. These 
values were calculated by 1000 simulations of 5 pulses with pulse variability = 0.5. Thus, 
the pulse interval is not very important. With an experimentally anticipated size of 
variability in pulse height and width, the height variability modulates the cumulative 
amount of p53 more than the pulse width.  
 Because of the variability amplification via the Hill formula, the apoptosis probability 
curves in Figure 5 become more hyperbolic with a larger Hill coefficient. Qualitatively 
similar results were also obtained by setting the pulse height to different values, e.g. the 
minimum pulse height for 3-pulse apoptosis induction (data not shown). Thus, the roles 
of the cooperativity of PUMA expression by p53 in the rigor of the cell fate decision 
found here were quite robust.  
 
Discussion and Conclusion 
 
 We investigated how a variable p53 pulse size affects the rigor of cell fate decision, 
and the roles of the cooperativity in PUMA expression regulation by p53. By variable 
pulse sizes, the rigorous cell fate decision was disrupted. As the variability in p53 pulse 
size increases, the probability of the apoptosis induction curve changes from sigmoidal 
to hyperbolic. As the cooperativity of PUMA expression by p53 increases, the rigor of 
the cell fate decision is more disrupted. Among the three types of pulse variability, pulse 
height variability was the most influential on perturbation because the cooperativity in 
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PUMA expression amplified the variability in stimulus.  
In the current study, we set the Hill coefficient of PUMA expression by p53 as 2.0 by 
default, following the in vitro experiment which showed that p53 binding to DNA has a 
Hill coefficient of 1.830; however, equation (7) in Table 1 for the PUMA expression by p53 
is a simple modeling that, in reality, includes many complex processes. Thus, not only 
cooperative binding of p53 to the promoter of the PUMA gene but also many other 
transcription and translation processes, such as chromatin remodeling or mRNA 
transport from the nucleus to cytoplasm, are included in the Stimulus term. Any factors 
which influence transcription and translation processes may change the cooperativity of 
gene expression by p53. Thus, it is possible that cells have various mechanisms to 
regulate the rigor of cell fate decision by controlling the cooperativity of gene expression 
by p53. 
 The suggestion of Sun et al. (2009) and the current work on the influence of 
cooperativity of the PUMA expression by p53 on the rigor of cell fate decision need to be 
verified experimentally. For this, firstly, a mutant and/or modified p53 that enhances the 
expression of PUMA with different levels of cooperativity will be required. Also, cells 
should be prepared which can stably express such types of p53 after DNA damage. 
Alternatively, a method to control the cooperativity of the gene expression by p53 could 
be used to verify our suggestion. Secondly, cells should be damaged by gamma ray 
radiation at different intensities to induce different numbers of p53 pulses. Finally, the 
relationship between the number of p53 pulses and the ratio of apoptotic cells should be 
examined. Using this type of experiment, experimental evidence will be obtained of the 
relationship between the rigor of the cell fate decision and the cooperativity of gene 
expression by p53. To accurately count the number of p53 pulses in individual cells, 
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single cell measurements as in time-lapse microscopy are thought to be suitable, as 
indicated in Lahav et al. (2004). 
 Although we limited ourselves to the p53 pulse counting mechanism of the Bax 
activation switch, other mechanisms are also possible. For example, downstream of the 
Bax activation switch, there exists a caspase cascade37. It is thought that because of the 
existence of a positive feedback loop in the caspase cascade, caspase-3 activation 
occurs in an all-or-none irreversible manner,, similarly to the Bax activation switch38. 
Although PUMA is the main transcriptional target of p53 in various tissues26-28, p53 is 
known to enhance the expression of Apaf-1 modestly25. Apaf-1 is known to form a 
complex with cytochrome c and to activate the caspase cascade37. Pulse-like 
concentration changes of p53 may influence Apaf-1 concentration and subsequent 
caspase cascade activation; therefore, the caspase cascade may also count the 
number of p53 pulses. Since the two counting mechanisms are not mutually exclusive, 
both the Bax activation switch and caspase cascade may count the number of p53 
pulses and decide the cell fate; however, even if the caspase cascade can count the 
number of p53 pulses, the influence of the cooperativity of gene expression by p53 is 
still thought to be important for the rigor of the cell fate decision, as indicated in the 
current study. The current study sheds light on the probabilistic nature of the cell fate 
decision, which may make cells fragile; however, homeostasis or the health of our 
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Fig. 1. Schematic diagram of the model. Solid arrows represent conformational change, 
dimerization or dissociation of the same protein, Bax. Dotted arrow from p53 to PUMA 
represents enhancement of transcription. Other dotted arrows represent activation. 
Dotted lines with horizontal bar represent inhibition. 
Abbreviations: AcBax: activated Bax, Act: activator BH3-only protein. 
 
Fig. 2. Examples of p53 pulses. Mean pulse height was set to 100.0 (nM) as an 
example. (A) An example in which the pulse heights, widths and intervals were set to 
constant mean values. (B) An example in which the pulse heights, widths, and interval 
varied. 
 
Fig. 3. Bifurcation diagrams of the model system. Red curves indicate stable steady 
states. Blue curves indicate unstable steady states. (A) Hill coefficient = 2.0 (default 
value). Threshold p53 concentration (position of solid arrow) equals 75.0 (nM) (B) Hill 
coefficient = 1.0. Threshold p53 concentration equals 11.0 (nM) (C) Hill coefficient = 4.0. 
Threshold p53 concentration equals 193.0 (nM). 
 
Fig. 4. Apoptosis percentage (Hill coefficient = 2.0).  
Blue curve: pulse variability = 0.0, Red curve: pulse variability = 0.25, Yellow curve: 
pulse variability = 0.5, Green curve: pulse variability = 1.0. 
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Fig. 5. Difference of apoptosis percentage among different Hill coefficient systems. (A) 
pulse variability = 0.25. (B) pulse variability = 0.5. (C) pulse variability = 1.0. 
Blue curve: Hill coefficient = 1.0, Red curve: Hill coefficient = 2.0, Green curve: Hill 
coefficient = 4.0. 
 
Fig. 6. Apoptosis percentage with constant pulse height or pulse width or pulse interval. 
(A)–(C) Pulse height was set to constant value. (A) pulse variability = 0.25. (B) pulse 
variability = 0.5. (C) pulse variability = 1.0. 
(D)–(F) Pulse width was set to constant value. (D) pulse variability = 0.25. (E) pulse 
variability = 0.5. (F) pulse variability = 1.0. 
(G)–(I) Pulse interval was set to constant value. (G) pulse variability = 0.25. (H) pulse 
variability = 0.5. (I) pulse variability = 1.0. 
Blue curve: Hill coefficient = 1.0, Red curve: Hill coefficient = 2.0, Green curve: Hill 




Table 1. Ordinary differential equations of the model. 
 = ksx – kdx [Bax]－kxa [Bax][Act] + kax [AcBax]  
– kaxx [AcBax][Bax]      (1)  
 = －kdax [AcBax] + kxa [Bax][Act]－kfaxb2 [AcBax][Bcl2]  
+ kraxb2 [AcBax/Bcl2]－kfaxab2 [AcBax][Act/Bcl2]  + kraxab2 [AcBax/Bcl2][Act] – kax [AcBax] 
－kfaxsb2 [AcBax][PUMA/Bcl2] + kraxsb2 [AcBax/Bcl2][PUMA] – kaxx [AcBax][Bax] – 2×kfaxax [AcBax]2 + 2×kraxax [Pore]    (2)  
 = ksb2－kdb2 [Bcl2] －kfaxb2 [AcBax][Bcl2] 
+ kraxb2 [AcBax/Bcl2]－kfab2 [Act][Bcl2] + krab2 [Act/Bcl2] 
－kfsb2 [PUMA][Bcl2] + krsb2 [PUMA/Bcl2]    (3)  
 = ksa – kda [Act]－kfab2 [Act][Bcl2]  
+ krab2 [Act/Bcl2] + kfaxab2 [AcBax][Act/Bcl2]  
－kraxab2 [AcBax/Bcl2][Act] – kfasb2 [Act][PUMA/Bcl2] + krasb2 [Act/Bcl2][PUMA]     (4)  
= －kdab2 [Act/Bcl2] + kfab2 [Act][Bcl2] 
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－krab2 [Act/Bcl2]－kfaxab2 [AcBax][Act/Bcl2]  + kraxab2 [AcBax/Bcl2][Act] + kfasb2 [Act][PUMA/Bcl2] －krasb2 [Act/Bcl2][PUMA]  (5)  
= －kdaxb2 [AcBax/Bcl2] + kfaxb2 [AcBax][Bcl2] 
－kraxb2 [AcBax/Bcl2] + kfaxab2 [AcBax][Act/Bcl2] 
－kraxab2 [AcBax/Bcl2][Act] + kfaxsb2 [AcBax][PUMA/Bcl2] 
－kraxsb2 [AcBax/Bcl2][PUMA]     (6)  
 = kss – kds [PUMA]－kfsb2 [PUMA][Bcl2] + krsb2 [PUMA/Bcl2]  
+ kfasb2 [Act][PUMA/Bcl2]－krasb2 [Act/Bcl2][PUMA] + kfaxsb2 [AcBax][PUMA/Bcl2] －kraxsb2 [AcBax/Bcl2][PUMA] + stimulus       (7)  
  
 = －kdsb2 [PUMA/Bcl2] + kfsb2 [PUMA][Bcl2]  
－krsb2 [PUMA/Bcl2]－kfasb2 [Act][PUMA/Bcl2]  + krasb2 [Act/Bcl2][PUMA]－kfaxsb2 [AcBax][PUMA/Bcl2] + kraxsb2 [AcBax/Bcl2][PUMA]     (8)  
 = －kdpo [Pore] + kaxx [AcBax][Bax] + kfaxax [AcBax]2 
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Table 2. Kinetic parameters of the model. 
Variable Value   unit  Reference 
Kp53  5.0e + 2   nM   (16) 
kssp53   2.0e + 1   nM min-1  (28) 
n   2.0e + 0   －   (30) 
ksx   2.0e + 1   nM min-1  (16) 
ksa   2.0e + 0   nM min-1  (16) 
ksb2   6.0e + 0   nM min-1  (16) 
kss   2.0e + 0   nM min-1  (16) 
kdx   3.0e－2   min-1   (16) 
kdax   2.0e－3   min-1   (16) 
kda   1.0e－2   min-1   (16) 
kdb2   2.0e－3   min-1   (16) 
kdab2   2.0e－3   min-1   (16) 
kdaxb2   1.0e－2   min-1   (16) 
kds   1.0e－3   min-1   (16) 
kdsb2   5.0e－3   min-1   (16) 
kdpo   1.0e－2   min-1   (16) 
kxa   1.0e－4   nM-1 min-1  (16) 
kfaxb2   1.0e－3   nM-1 min-1  (16) 
kraxb2   1.0e－3   min-1   (16) 
kfab2   1.0e－2   nM-1 min-1  (16) 
krab2   6.0e－2   min-1   (16) 
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kfaxab2   5.0e－4   nM-1 min-1  (16) 
kraxab2   1.0e－5   nM-1 min-1  (16) 
kax   1.0e－3   min-1   (16) 
kfsb2   1.0e－4   nM-1 min-1  (16) 
krsb2   1.0e－3   min-1   (16) 
kfasb2   5.0e－5   nM-1 min-1  (16) 
krasb2   5.0e－4   nM-1 min-1  (16) 
kfaxsb2   5.0e－4   nM-1 min-1  (16) 
kraxsb2   1.0e－2   nM-1 min-1  (16) 
kaxx   2.0e－4   nM-1 min-1  (16) 
kfaxax   2.0e－4   nM-1 min-1  (16) 














Table 3. Minimum pulse height needed for apoptosis. 
Table 3A. Hill coefficient = 1.0 
p53 pulse number    p53 pulse height (nM) 
1      158.0 
2      88.0 
3      67.0 
4      57.0 
5      51.0 
 
Table 3B. Hill coefficient = 2.0 
p53 pulse number    p53 pulse height (nM) 
1      343.0 
2      254.0 
3      221.0 
4      203.0 
5      192.0 
 
Table 3C. Hill coefficient = 4.0 
p53 pulse number    p53 pulse height (nM) 
1      464.0 
2      394.0 
3      366.0 
4      351.0 
5      341.0 
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Table 4. Relationship between p53 concentration and the value of Stimulus term. 
Here shows pulse variability = 0.5 as an example. 
HC pulse height (nM) ST range (nM/min) RWS (nM/min) NRWS 
1.0 50.375–104.625  1.831–3.461  1.630  0.607 
2.0 154.375–320.625 1.741–5.828  4.087  1.110 
4.0 247.000–513.000 1.124–10.513  9.389  1.877 
Abbreviations: HC: Hill coefficient. ST range: Stimulus term range 















        Fig.3.A 
 










          Fig.5.A        Fig.5.B    Fig.5.C 
 
37 
 
 
 
 
